Ergomed Gross profit (FY, 2017)14.6 M

Ergomed Gross profit margin (FY, 2017), %30.7%

Ergomed Net income (FY, 2017)-4.5 M

Ergomed EBITDA (FY, 2017)-2.3 M

Ergomed EBIT (FY, 2017)-3.9 M

Ergomed Cash, 31-Dec-20173.2 M

Ergomed revenue was £47.62 m in FY, 2017

Ergomed revenue breakdown by business segment: 27.4% from Drug safety and medical information services and 72.6% from Clinical research services

GBP | FY, 2003 | FY, 2005 | FY, 2006 | FY, 2007 | FY, 2008 | FY, 2009 | FY, 2010 | FY, 2011 | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|

## Revenue | 3 m | 4.3 m | 4.9 m | 7 m | 8.1 m | 9.6 m | 9.9 m | 12.1 m | 14.6 m | 15.1 m | 21.2 m | 30.2 m | 39.2 m | 47.6 m |

| 40% | 43% | 30% | |||||||||||

## Cost of goods sold | 2.6 m | 3.4 m | 3.7 m | 5.7 m | 6 m | 6.4 m | 6.9 m | 8.1 m | 10.7 m | 10.1 m | 15.4 m | 21.8 m | 27.2 m | 33 m |

## Gross profit | 404 k | 918.5 k | 1.2 m | 1.3 m | 2.1 m | 3.2 m | 3 m | 4 m | 3.9 m | 5 m | 5.8 m | 8.4 m | 12 m | 14.6 m |

| 13% | 22% | 24% | 19% | 26% | 33% | 30% | 33% | 27% | 33% | 27% | 28% | 31% | 31% |

## Operating expense total | 112.7 k | 581.8 k | 892.6 k | 850.4 k | 2.1 m | 2.8 m | 2.7 m | 3.3 m | 3.5 m | 3.2 m | 5 m | 6.3 m | 11.9 m | 18.5 m |

## EBITDA | 509.7 k | 169.3 k | 462.4 k | 370.8 k | 670.5 k | 522 k | 1.8 m | 852 k | 2.2 m | 1.1 m | (2.3 m) | |||

| 7% | 2% | 5% | 4% | 6% | 4% | 12% | 4% | 7% | 3% | (5%) | |||

## EBIT | 291.4 k | 336.6 k | 303.5 k | 494.9 k | 20.3 k | 357.7 k | 306.4 k | 619.7 k | 465 k | 1.8 m | 779 k | 2.1 m | 49 k | (3.9 m) |

| 10% | 8% | 6% | 7% | 0% | 4% | 3% | 5% | 3% | 12% | 4% | 7% | 0% | (8%) |

## Pre tax profit | 299 k | 337.6 k | 306.3 k | 498.4 k | (12.4 k) | 312.5 k | 308.9 k | 633.2 k | 474 k | 1.8 m | 777 k | 2.1 m | (223 k) | (4.4 m) |

## Income tax expense | (82.1 k) | (103.1 k) | (93.5 k) | (154.6 k) | (27.3 k) | (188 k) | (98.9 k) | (98.4 k) | (83 k) | (232 k) | (199 k) | (520 k) | 153 k | (57 k) |

## Net Income | 216.8 k | 234.4 k | 212.9 k | 343.8 k | (39.7 k) | 124.5 k | 209.9 k | 534.7 k | 391 k | 1.5 m | 578 k | 1.6 m | (70 k) | (4.5 m) |

- Source: Company Filings 2015

GBP | FY, 2001 | FY, 2002 | FY, 2003 | FY, 2004 | FY, 2005 | FY, 2006 | FY, 2007 | FY, 2008 | FY, 2009 | FY, 2010 | FY, 2011 | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|

## Cash | 3 k | 14.7 k | 668.9 k | 739.5 k | 143.2 k | 545.6 k | 452.5 k | 692.3 k | 467.9 k | 1 m | 642.2 k | 445 k | 2 m | 4.6 m | 4 m | 4.4 m | 3.2 m |

## Accounts Receivable | 527.2 k | 867 k | 834 k | 1.8 m | 860.5 k | 2.1 m | 1.3 m | 3.1 m | 2.3 m | 2.3 m | 4.7 m | 6.4 m | 12.1 m | 15.8 m | |||

## Current Assets | 3 k | 117.7 k | 1.3 m | 1.5 m | 1.3 m | 1.9 m | 3.1 m | 1.9 m | 3.1 m | 2.9 m | 4.4 m | 4 m | 5.2 m | 10.9 m | 13.5 m | 19.6 m | 23 m |

## PP&E | 100 k | 86.4 k | 72.9 k | 58.3 k | 17 k | 476.1 k | 158.8 k | 175.7 k | 154.5 k | 164 k | 148 k | 185 k | 335 k | 717 k | 1.1 m | ||

## Goodwill | 1.3 m | 10.2 m | 10.3 m | 32.1 m | |||||||||||||

## Total Assets | 3 k | 117.7 k | 1.4 m | 1.6 m | 1.4 m | 2 m | 3.3 m | 2.4 m | 3.4 m | 3.1 m | 4.5 m | 4.2 m | 6.7 m | 21.7 m | 24.7 m | 54.2 m | 61.9 m |

## Accounts Payable | 253.2 k | 285.1 k | 240.1 k | 423.3 k | 653.4 k | 998.3 k | 834.8 k | 1.4 m | 2.4 m | 2.5 m | 2.7 m | 2.4 m | 3 m | 4.9 m | |||

## Current Liabilities | 302 | 97.2 k | 1.1 m | 1.3 m | 1.1 m | 1.4 m | 2.5 m | 2.4 m | 3.1 m | 2.9 m | 3.8 m | 3.8 m | 4.8 m | 5.8 m | 7.2 m | 8.6 m | 13.9 m |

## Non-Current Liabilities | 22.2 k | 17.8 k | 13.6 k | 9.3 k | 4.9 k | 18.9 k | 17.8 k | 9.4 k | 4.6 k | 31 k | 8 k | 581 k | 523 k | 11.2 m | 13.2 m | ||

## Total Debt | 263 | 294.4 k | 46.3 k | 67 k | 22 k | 7 k | 5 k | 3 k | |||||||||

## Total Liabilities | 302 | 97.2 k | 1.1 m | 1.4 m | 1.1 m | 1.4 m | 2.5 m | 2.4 m | 3.1 m | 2.9 m | 3.8 m | 3.9 m | 4.8 m | 6.3 m | 7.8 m | 19.8 m | 27.1 m |

## Additional Paid-in Capital | 2 | 2 | 2 | 2 | 2 | 1 k | 200 k | 200 k | 200 k | 200 k | 200 k | 200 k | 200 k | 288 k | 288 k | 406 k | 428 k |

## Retained Earnings | 216.8 k | 84.4 k | 212.9 k | 143.8 k | (119.7 k) | 124.5 k | 29.9 k | 534.7 k | (409 k) | 1.5 m | 578 k | 1.6 m | (70 k) | (4.5 m) | |||

## Total Equity | 2.7 k | 20.5 k | 237.4 k | 238.2 k | 322.6 k | 535.5 k | 750.7 k | 2.1 k | 258.6 k | 271 k | 746.5 k | 353 k | 1.9 m | 15.3 m | 16.9 m | 34.4 m | 34.8 m |

## Debt to Equity Ratio | 0 x | 137.3 x | 0.2 x | 0.2 x | 0 x | 0 x | 0 x | 0 x | |||||||||

## Debt to Assets Ratio | 0 x | 0.1 x | 0 x | 0 x | 0 x | 0 x | 0 x | 0 x | |||||||||

## Financial Leverage | 1.1 x | 5.7 x | 5.8 x | 6.7 x | 4.3 x | 3.7 x | 4.4 x | 1.1 k x | 13 x | 11.6 x | 6.1 x | 12 x | 3.5 x | 1.4 x | 1.5 x | 1.6 x | 1.8 x |

GBP | FY, 2003 | FY, 2005 | FY, 2006 | FY, 2007 | FY, 2008 | FY, 2009 | FY, 2010 | FY, 2011 | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|

## Net Income | 216.8 k | 234.4 k | 212.9 k | 343.8 k | (39.7 k) | 124.5 k | 209.9 k | 534.7 k | 391 k | 1.5 m | 578 k | 1.6 m | (70 k) | (4.5 m) |

## Cash From Operating Activities | 191.7 k | 334.4 k | (339.2 k) | 969 k | (361.9 k) | 581 k | 1.4 m | 537 k | 264 k | (2.4 m) | 26 k | |||

## Dividends Paid | 150 k | 200 k | 180 k | 800 k | ||||||||||

## Cash From Financing Activities | (36.1 k) | (99.4 k) | (351.7 k) | (15.9 k) | (710 k) | (68 k) | 9.1 m | (1 k) | 8.7 m | 2.7 m | ||||

## Net Change in Cash | (92.8 k) | 161.8 k | (224.4 k) | 572.3 k | (398 k) | (197 k) | 1.5 m | 2.6 m | (602 k) | 450 k | (1.2 m) | |||

## Income Taxes Paid | (232 k) | (199 k) | (520 k) | 153 k |

GBP | Y, 2017 |
---|---|

## Revenue/Employee | 317.5 k |

## Financial Leverage | 1.8 x |

Report incorrect company information

Ergomed's Customers was reported to be 100 in FY, 2015.

FY, 2015 | |
---|---|

## Countries | 54 |

## Customers | 100 |

## Patients Studied | 30 k |

Report incorrect company information